Arrow Research search

Author name cluster

Yu Bao

Possible papers associated with this exact author name in Arrow. This page groups case-insensitive exact name matches and is not a full identity disambiguation profile.

5 papers
2 author rows

Possible papers

5

TMLR Journal 2025 Journal Article

Decomposed Direct Preference Optimization for Structure-Based Drug Design

  • Xiwei Cheng
  • Xiangxin Zhou
  • Yuwei Yang
  • Yu Bao
  • Quanquan Gu

Diffusion models have achieved promising results for Structure-Based Drug Design (SBDD). Nevertheless, high-quality protein subpocket and ligand data are relatively scarce, which hinders the models’ generation capabilities. Recently, Direct Preference Optimization (DPO) has emerged as a pivotal tool for aligning generative models with human preferences. In this paper, we propose DecompDpo, a structure-based optimization method aligns diffusion models with pharmaceutical needs using multi-granularity preference pairs. DecompDpo introduces decomposition into the optimization objectives and obtains preference pairs at the molecule or decomposed substructure level based on each objective’s decomposability. Additionally, DecompDpo introduces a physics-informed energy term to ensure reasonable molecular conformations in the optimization results. Notably, DecompDpo can be effectively used for two main purposes: (1) fine-tuning pretrained diffusion models for molecule generation across various protein families, and (2) molecular optimization given a specific protein subpocket after generation. Extensive experiments on the CrossDocked2020 benchmark show that DecompDpo significantly improves model performance, achieving up to 98.5% Med. High Affinity and a 43.9% success rate for molecule generation, and 100% Med. High Affinity and a 52.1% success rate for targeted molecule optimization.

AAAI Conference 2024 Conference Paper

Binding-Adaptive Diffusion Models for Structure-Based Drug Design

  • Zhilin Huang
  • Ling Yang
  • Zaixi Zhang
  • Xiangxin Zhou
  • Yu Bao
  • Xiawu Zheng
  • Yuwei Yang
  • Yu Wang

Structure-based drug design (SBDD) aims to generate 3D ligand molecules that bind to specific protein targets. Existing 3D deep generative models including diffusion models have shown great promise for SBDD. However, it is complex to capture the essential protein-ligand interactions exactly in 3D space for molecular generation. To address this problem, we propose a novel framework, namely Binding-Adaptive Diffusion Models (BindDM). In BindDM, we adaptively extract subcomplex, the essential part of binding sites responsible for protein-ligand interactions. Then the selected protein-ligand subcomplex is processed with SE(3)-equivariant neural networks, and transmitted back to each atom of the complex for augmenting the target-aware 3D molecule diffusion generation with binding interaction information. We iterate this hierarchical complex-subcomplex process with cross-hierarchy interaction node for adequately fusing global binding context between the complex and its corresponding subcomplex. Empirical studies on the CrossDocked2020 dataset show BindDM can generate molecules with more realistic 3D structures and higher binding affinities towards the protein targets, with up to -5.92 Avg. Vina Score, while maintaining proper molecular properties. Our code is available at https://github.com/YangLing0818/BindDM

ICLR Conference 2024 Conference Paper

DecompOpt: Controllable and Decomposed Diffusion Models for Structure-based Molecular Optimization

  • Xiangxin Zhou
  • Xiwei Cheng
  • Yuwei Yang
  • Yu Bao
  • Liang Wang 0001
  • Quanquan Gu

Recently, 3D generative models have shown promising performances in structure-based drug design by learning to generate ligands given target binding sites. However, only modeling the target-ligand distribution can hardly fulfill one of the main goals in drug discovery -- designing novel ligands with desired properties, e.g., high binding affinity, easily synthesizable, etc. This challenge becomes particularly pronounced when the target-ligand pairs used for training do not align with these desired properties. Moreover, most existing methods aim at solving de novo design task, while many generative scenarios requiring flexible controllability, such as R-group optimization and scaffold hopping, have received little attention. In this work, we propose DecompOpt, a structure-based molecular optimization method based on a controllable and decomposed diffusion model. DecompOpt presents a new generation paradigm which combines optimization with conditional diffusion models to achieve desired properties while adhering to the molecular grammar. Additionally, DecompOpt offers a unified framework covering both de novo design and controllable generation. To achieve so, ligands are decomposed into substructures which allows fine-grained control and local optimization. Experiments show that DecompOpt can efficiently generate molecules with improved properties than strong de novo baselines, and demonstrate great potential in controllable generation tasks.

ICML Conference 2023 Conference Paper

DecompDiff: Diffusion Models with Decomposed Priors for Structure-Based Drug Design

  • Jiaqi Guan
  • Xiangxin Zhou
  • Yuwei Yang
  • Yu Bao
  • Jian Peng 0001
  • Jianzhu Ma
  • Qiang Liu 0006
  • Liang Wang 0001

Designing 3D ligands within a target binding site is a fundamental task in drug discovery. Existing structured-based drug design methods treat all ligand atoms equally, which ignores different roles of atoms in the ligand for drug design and can be less efficient for exploring the large drug-like molecule space. In this paper, inspired by the convention in pharmaceutical practice, we decompose the ligand molecule into two parts, namely arms and scaffold, and propose a new diffusion model, DecompDiff, with decomposed priors over arms and scaffold. In order to facilitate the decomposed generation and improve the properties of the generated molecules, we incorporate both bond diffusion in the model and additional validity guidance in the sampling phase. Extensive experiments on CrossDocked2020 show that our approach achieves state-of-the-art performance in generating high-affinity molecules while maintaining proper molecular properties and conformational stability, with up to $-8. 39$ Avg. Vina Dock score and $24. 5%$ Success Rate. The code is provided at https: //github. com/bytedance/DecompDiff

AAAI Conference 2023 Conference Paper

Selective Knowledge Distillation for Non-Autoregressive Neural Machine Translation

  • Min Liu
  • Yu Bao
  • Chengqi Zhao
  • Shujian Huang

Benefiting from the sequence-level knowledge distillation, the Non-Autoregressive Transformer (NAT) achieves great success in neural machine translation tasks. However, existing knowledge distillation has side effects, such as propagating errors from the teacher to NAT students, which may limit further improvements of NAT models and are rarely discussed in existing research. In this paper, we introduce selective knowledge distillation by introducing an NAT evaluator to select NAT-friendly targets that are of high quality and easy to learn. In addition, we introduce a simple yet effective progressive distillation method to boost NAT performance. Experiment results on multiple WMT language directions and several representative NAT models show that our approach can realize a flexible trade-off between the quality and complexity of training data for NAT models, achieving strong performances. Further analysis shows that distilling only 5% of the raw translations can help an NAT outperform its counterpart trained on raw data by about 2.4 BLEU.

v2026.09.13